Filing Details
- Accession Number:
- 0001325812-13-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-18 19:26:46
- Reporting Period:
- 2013-12-16
- Filing Date:
- 2013-12-18
- Accepted Time:
- 2013-12-18 19:26:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1514291 | Michael Mason | 300 Third Street Cambridge MA 02142 | Vp, Finance And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-16 | 2,000 | $9.14 | 9,847 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-12-16 | 3,000 | $10.98 | 12,847 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-12-16 | 3,000 | $16.43 | 15,847 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-16 | 5,800 | $60.20 | 10,047 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-12-16 | 2,200 | $60.77 | 7,847 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-12-16 | 2,000 | $0.00 | 2,000 | $9.14 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-12-16 | 3,000 | $0.00 | 3,000 | $10.98 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-12-16 | 3,000 | $0.00 | 3,000 | $16.43 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2013-12-18 | 5,000 | $0.00 | 5,000 | $63.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,563 | 2020-12-08 | No | 4 | M | Direct | |
| 9,500 | 2021-02-28 | No | 4 | M | Direct | |
| 0 | 2019-12-10 | No | 4 | M | Direct | |
| 5,000 | 2023-12-18 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,906 | Indirect | by Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan.
- Sale prices ranged from $59.62 to $60.61.
- Sale prices ranged from $60.64 to $60.98.
- The reporting person owns 1,906 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Billionaire Hedge Funds
